TJP1 and neoplasm: FHL1 was identified functionally interacted with oestrogen receptors (ERs), Smad2/3/4, HIF-1, human T-cell leukemia virus type 1 Tax oncoprotein and ZO-1 in various cancer types [30–34], suggesting that its functions as either a tumor suppressor or oncoprotein.